Zobrazeno 1 - 10
of 185
pro vyhledávání: '"F. G. M. Russel"'
Autor:
F. G. M. Russel
Publikováno v:
Algemene farmacologie ISBN: 9789036819466
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c8a728de6cc825e6b68187c3f35e39b
https://doi.org/10.1007/978-90-368-1946-6_5
https://doi.org/10.1007/978-90-368-1946-6_5
Autor:
F. G. M. Russel
Publikováno v:
Algemene farmacologie ISBN: 9789036819466
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::660007be757817d867b3373c6e6cedcc
https://doi.org/10.1007/978-90-368-1946-6_4
https://doi.org/10.1007/978-90-368-1946-6_4
Publikováno v:
British journal of pharmacology. 155(7)
The xanthine oxidase inhibitors allopurinol and oxypurinol are used to treat hyperuricaemia, whereas loop and thiazide diuretics can cause iatrogenic hyperuricaemia. Some uricosuric drugs and salicylate have a bimodal action on urate renal excretion.
Publikováno v:
BJU international. 92(4)
To study the pathophysiological changes of renal tubular drug transport mechanisms in congenital renal obstruction, by developing a model for perfusing the isolated kidney (IPK) after neonatal surgical induction of partial ureteric obstruction in Han
Autor:
E J, Abbink, P, Pickkers, A, Jansen van Rosendaal, J A, Lutterman, C J, Tack, F G M, Russel, P, Smits
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 19(2)
Glibenclamide attenuates the protective responses to opening of vascular ATP-sensitive potassium (K(ATP)) channels during ischaemia. Therefore, glibenclamide treatment of Type 2 diabetes mellitus may have hazardous cardiovascular effects when used un
Autor:
E J, Abbink, P, Pickkers, A Jansen, van Rosendaal, J A, Lutterman, C J, Tack, F G M, Russel, P, Smits
Publikováno v:
Clinical science (London, England : 1979). 102(3)
Glibenclamide inhibits the opening of vascular ATP-sensitive potassium (K(ATP)) channels, which represents a protective mechanism during ischaemia. This effect may imply harmful cardiovascular effects of glibenclamide when used under conditions of is
Autor:
El-Sheikh, Azza A.K., Greupink, Rick, Wortelboer, Heleen M., van den Heuvel, Jeroen J.M.W., Schreurs, Marieke, Koenderink, Jan B., Masereeuw, Rosalinde, Russel, Frans G.M.
Publikováno v:
In Translational Research December 2013 162(6):398-409
Autor:
Cheng, Jingyun1 (AUTHOR), Huang, Hui2 (AUTHOR) huanghuish@shu.edu.cn, Chen, Yu2,3 (AUTHOR) chenyuedu@shu.edu.cn, Wu, Rong1 (AUTHOR) wurong7111@sjtu.edu.cn
Publikováno v:
Advanced Science. 12/27/2023, Vol. 10 Issue 36, p1-46. 46p.
Autor:
Shaughnessey EM; Draper Scholar, The Charles Stark Draper Laboratory Inc., 555 Technology Square, Cambridge, MA, 02139, USA.; Department of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA, 02155, USA., Kann SH; Draper Scholar, The Charles Stark Draper Laboratory Inc., 555 Technology Square, Cambridge, MA, 02139, USA.; Department of Mechanical Engineering, Boston University, 110 Cummington Mall, Boston, MA, 02215, USA., Charest JL; The Charles Stark Draper Laboratory Inc., 555 Technology Square, Cambridge, MA, 02139, USA., Vedula EM; The Charles Stark Draper Laboratory Inc., 555 Technology Square, Cambridge, MA, 02139, USA.
Publikováno v:
Advanced biology [Adv Biol (Weinh)] 2024 Jan; Vol. 8 (1), pp. e2300127. Date of Electronic Publication: 2023 Oct 02.
Autor:
F. W. H. M. Merkus, F. W. J. Gribnau, Th. Thien, Hans W. Louwerenburg, J. Herre Kingma, Wiek H. van Gilst, A. Jacob Six, Pieter de Graeff, Harry Wesseling, J. R. BoeLaert, M. L. Schurgers, E. G. Matthys, F. Belpaire, R. F. Daneels, M. J. de Cre, M. G. Boqaert, P. C. D'Haese, G. A. Verpooten, L. V. Lamberts, L. Liang, M. E. de Broe, P. H. E. M. de Meijer, F. G. M. Russel, A. J. M. Russel, C. A. M. van Ginneken, B. M. van Liedekerke, W. E. Lambert, M. A. Yousouf, J. E. de Roose, A. P. de Leenheer, W. Lambert, J. de Bersaques, L. Vanneste, A. de Leenheer, S. de Marie, G. Slaghuis, P. M. Rozing, H. Mattie, F. G. J. Poelma, H. W. Hilbers, A. C. A. Jansen, J. J. Tukker, P. Augusti, N. Verbeke, A. van Peer, E. Snoeck, J. Heykants, J. Bruynseels, J. Peeters, W. Amery, V. Rogiers, Y. Vandenberghe, M. Comet, A. Callaerts, W. Sonck, A. Guillouzo, A. Vercruysse, P. van Rooy, N. Rombaut, G. vanden Bussche, A. C. I. T. L. Tan, T. L. Th. A. Jansen, E. F. S. Termond, P. W. C. Kloppenborg, Th. J. Benraad, V. van de Velde, R. Woestenbprghs, W. A. J. J. Hermens, S. G. Romeijn, M. J. M. Deurloo, G. Musch, D. L. Massart, M. van Hengstum, J. Festen, W. van den Broek, F. Corstens, C. Beurskens, M. Hankel, M. de Smet, S. J. P. van Belle, J. de May, G. A. Storme, P. J. K. Kuppen, H. Schuitemaker, L. J. van't Veer, A. T. van Oosterom, P. I. Schrier, E. A. de Bruijn, C. H. de Pooter, U. R. Tjaden, H. van Slooten, H. P. Roelevink, E. Smit, E. G. E. de Vries, J. Ijmker, D. R. A. Uges, M. Moors, K. Mertens, A. van Hecken, I. de Lepeleire, R. Verbesselt, T. B. Tjandra-Maga, P. J. de Schepper, P. J. M. Guelen, T. J. Jansen, W. P. Vrijhof, D. de Vos, S. Scharpé, R. Verkerk, N. Lsmeire, I. F. Zijlstra, F. M. Haaijer-Ruskamp, D. Post, P. F. Reddingius, H. Wesseling, H. C. H. Wollersheim, A. H. van den Meiracker, A. J. Man in 't Veld, P. Admiraal, F. Boomsma, F. Derkx, M. A. D. H. Schalekamp, D. F. Schoors, A. G. Dupont, F. Claessen, J. Reljenga, J. W. M. Lenders, Th. Thlen, G. Laekeman, L. Muylle, A. van Hoydonck, A. G. Herman, M. E. Peetermans
Publikováno v:
Pharmaceutisch Weekblad. 10:291-299